News
Wasdell Group Wins Contract to Provide Direct-to-Patient Distribution Pharmacy Services
The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has secured a new contract to supply medicines and dietary supplements directly to consumers from its Swindon site.
The partnership with a major healthcare company will see Wasdell...
News
Teckro launches new software to streamline clinical trials
The company uses machine-learning technology to transform clinical trial protocols from static documents into actionable data for research staff, monitors and sponsors.
Users on the platform receive up-to-date study information and with the new software additions, can now provide feedback...
News
Advantexe Wins Gold for Best Advance in Leadership Simulation from Brandon Hall Group
Advantexe, a global leader in business simulation centric talent development solutions, announced that they have won a 2019 Gold Medal for Best Advance in Leadership Simulation Technology from the Brandon Hall Group for their “Pharmaceutical Business Simulation.”
The simulation is...
News
Inceptua announced that Paul Wituschek has been appointed President North America
Inceptua announced that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January, 2020.
Paul will take on...
Clinical Trials
Janssen to Acquire Investigational Bermekimab from XBiotech
Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody (mAb) in...
News
Recipharm invests in its US inhalation development service
Recipharm, the contract development and manufacturing organisation (CDMO), has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW® system that will support inhalation and nasal product development.
The newly acquired system was...
News
Sanofi Lines Up for Potential Approval of Cold Agglutinin Disease Treatment
Following positive results from a pivotal Phase III trial assessing the safety and efficacy of sutimlimab in people with primary cold agglutinin disease (CAD), Sanofi is making plans to seek regulatory approval of the medication in the United States.
France-based...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read